MedPath

安徽城市药业股份有限公司

Ownership
-
Established
2004-04-02
Employees
-
Market Cap
-
Website
http://www.ahcsyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

151

NMPA:151

Drug Approvals

三肾温阳酒

Approval Number
国药准字Z20027804
Approval Date
Aug 11, 2021
NMPA

Paracetamol Tablets

Product Name
对乙酰氨基酚片
Approval Number
国药准字H34020461
Approval Date
Jul 9, 2021
NMPA

Paracetamol Tablets

Product Name
对乙酰氨基酚片
Approval Number
国药准字H34020462
Approval Date
May 8, 2021
NMPA

Paracetamol Tablets

Product Name
对乙酰氨基酚片
Approval Number
国药准字H34020621
Approval Date
May 8, 2021
NMPA

Sulfamidine Tablets

Product Name
磺胺脒片
Approval Number
国药准字H34021838
Approval Date
May 8, 2021
NMPA

Nitrazepam Tablets

Product Name
硝西泮片
Approval Number
国药准字H34021994
Approval Date
Apr 1, 2021
NMPA

Cimetidine Tablets

Product Name
西咪替丁片
Approval Number
国药准字H34021717
Approval Date
Feb 26, 2021
NMPA

Vitamin C Tablets

Product Name
维生素C片
Approval Number
国药准字H34020631
Approval Date
Feb 26, 2021
NMPA

Vitamin C Tablets

Product Name
维生素C片
Approval Number
国药准字H34020629
Approval Date
Feb 26, 2021
NMPA

Vitamin C Chewable Tablets

Product Name
维生素C咀嚼片
Approval Number
国药准字H34022152
Approval Date
Feb 26, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 16
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.